HawkInsight

  • Contact Us
  • App
  • English
<IPO> NANSHAN AL INTL(02610.HK) Closes Down 5.1% to $25.25
5hour ago0
<IPO> NANSHAN AL INTL(02610.HK) Closes Down 3.2% to $25.75 at Midday
1hour ago0
<IPO> NANSHAN AL INTL(02610.HK) Opens Flat at $26.6 on Debut
1hour ago0
<IPO>Nanshan Al Int&#39;l(02610.HK) Closes Down 0.8% to $26.4 on Gray Mkt
16hour ago0
<IPO>Nanshan Al Int&#39;l(02610.HK) Opens Flat at $26.6 on Gray Mkt
17hour ago0
<IPO>Hangzhou&#39;s Little Dragon Manycore Tech Applies for HK Listing, Said to Raise US$200M
1 day ago0
<IPO>Duality Biotherapeutics Passes Listing Hearing of Stock Exchange
1 day ago0
<IPO> VISEN PHARMA-B(02561.HK) Closes Flat at $68.8
03-210
<IPO> VISEN PHARMA-B(02561.HK) Closes Down 2.3% to $67.2 at Midday
03-210
SFC Issues Guidelines Limiting IPO Margin Lending to 90%
03-210
<IPO> VISEN PHARMA-B(02561.HK) Opens Flat at $68.8 on Debut
03-210
<IPO>VISEN PHARMA-B (02561.HK) Public Offering 71x+ Oversubscribed; 1-lot Success Rate 6.27%
03-210
<IPO>VISEN Pharma-B(02561.HK) Closes Down 7.2% to $63.85 on Gray Mkt
03-200
<IPO>VISEN Pharma-B(02561.HK) Opens Down 5.5% to $65 on Gray Mkt
03-200
<IPO>SOFT INTL Intends to Expand Coverage in Southeast Asian Mkt
03-200
<IPO>Distinct Healthcare Reapplies for HK Listing; TENCENT Holds ~20% Stake, WB-SW CEO Appointed as INED
03-200
<IPO>SOFT INTL (02569.HK) IPO Starts Tdy; 1-lot Entry Fee $3,030.25
03-200
<IPO>VISEN PHARMA-B (02561.HK) Margin Oversubscription 8x+ So Far
03-141.95w
Paul Chan Envisages HK IPO Fundraising to Whop HKD156B This Yr, Up 82% YoY
03-132.03w
<IPO>Lens Tech (300433.SZ) Plans H-Shr Issuance for HK Listing
03-132.02w
<IPO>AI Drug Startup Insilico Medicine Reportedly Plans to Relaunch HK IPO w/ US$1B+ Valuation
03-122.06w
<IPO>CN EV Maker Avatr Technology Plans HK IPO, Raising US$1B: Rumor
03-122.07w
IPO Platform FINI loophole Found; HK SFC: Brokers Have Responsibility to Ensure Clients Meet System Requirements
03-112.09w
<IPO>MUYUAN (002714.SZ) Mulling Secondary Listing in HK This Yr Soonest, Raising Min. US$1B
03-102.08w
More
ugc
Robin
210articles
Peel off the threads and grasp the development trajectory of the enterprise
Follow